Contact
Please use this form to send email to PR contact of this press release:
Kiniksa Announces FDA Approval of ARCALYST ® (rilonacept) for Recurrent Pericarditis
TO:
Please use this form to send email to PR contact of this press release:
Kiniksa Announces FDA Approval of ARCALYST ® (rilonacept) for Recurrent Pericarditis
TO: